Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Jen Yu

Showing results (451-460 of 478) with videos related to

Pageof 48
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.
Oncotarget|December 13, 2017
EGFR mutation, smoking, and gender in advanced lung adenocarcinomaChien-Hua Tseng, Chun-Ju Chiang, Jeng-Sen Tseng, et al.
Plos One|March 20, 2015
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanKuo-Hsuan Hsu, Chao-Chi Ho, Te-Chun Hsia, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 8, 2019
Recommendations and guidelines for the treatment of pneumonia in TaiwanChih-Chen Chou, Ching-Fen Shen, Su-Jung Chen, et al.
Carcinogenesis|December 10, 2015
EGFR mutation and lobar location of lung adenocarcinomaChien-Hua Tseng, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2023
Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung CancerChi-Liang Wang, Kuo-Hsuan Hsu, Ya-Hsuan Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical ActionabilityHsuan-Yu Chen, Sung-Liang Yu, Bing-Ching Ho, et al.
Pageof 48

Showing results (451-460 of 478) with videos related to

Sort By:
Pageof 48
Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.
Oncotarget|December 13, 2017
EGFR mutation, smoking, and gender in advanced lung adenocarcinomaChien-Hua Tseng, Chun-Ju Chiang, Jeng-Sen Tseng, et al.
Plos One|March 20, 2015
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanKuo-Hsuan Hsu, Chao-Chi Ho, Te-Chun Hsia, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 8, 2019
Recommendations and guidelines for the treatment of pneumonia in TaiwanChih-Chen Chou, Ching-Fen Shen, Su-Jung Chen, et al.
Carcinogenesis|December 10, 2015
EGFR mutation and lobar location of lung adenocarcinomaChien-Hua Tseng, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2023
Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung CancerChi-Liang Wang, Kuo-Hsuan Hsu, Ya-Hsuan Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical ActionabilityHsuan-Yu Chen, Sung-Liang Yu, Bing-Ching Ho, et al.
Pageof 48